Voor wie we er zijnOnze wetenschapProductenResultaten
InloggenVraagAan de slagvanaf $ 449
Kenmerk
Can't control feelings
Klinische naam: Emotional lability
Unstable emotional experiences and frequent mood changes; emotions that are easily aroused, intense, and/or disproportionate to events and circumstances.
Samenvatting
- Ook bekend als
- Emotional instability, Mood lability
- Lichaamssysteem
- Abnormality of the nervous system
Can't control feelingsHP:0000712
Voor wie we er zijnOnze wetenschapProductenResultaten
InloggenVraagAan de slagvanaf $ 449
Read the genes linked to Can't control feelings, and the rest of your genome, with one test.
Vanaf $ 449Gratis verzending · Resultaten binnen 6–8 weken
Mijn Genome Test bestellen168 genen gekoppeld aan Can't control feelings
Veranderingen in deze genen veroorzaken zeldzame aandoeningen waarbij Can't control feelings voorkomt. De meeste mensen met dit kenmerk hebben geen van die aandoeningen, en een gen op deze lijst zegt niets over het eigen genoom van iemand.
| Gen | Hoe vaak het voorkomt | Aandoeningen |
|---|---|---|
| DEAF1DEAF1 transcription factor | Altijd | In 3 aandoeningen |
| LEPRleptin receptor | Altijd | In 2 aandoeningen |
| LRRC7leucine rich repeat containing 7 | Altijd | In 1 aandoening |
| PDCD6IPprogrammed cell death 6 interacting protein | Altijd | In 1 aandoening |
| RRP12ribosomal RNA processing 12 homolog | Altijd | In 1 aandoening |
| CASRcalcium sensing receptor | Heel vaak (80–99%) | In 1 aandoening |
| CLTRNcollectrin, amino acid transport regulator | Heel vaak (80–99%) | In 1 aandoening |
| DDCdopa decarboxylase | Heel vaak (80–99%) | In 1 aandoening |
| GNA11G protein subunit alpha 11 | Heel vaak (80–99%) | In 1 aandoening |
| HDAC8histone deacetylase 8 | Heel vaak (80–99%) | In 1 aandoening |
| LAS1LLAS1 like ribosome biogenesis factor | Heel vaak (80–99%) | In 2 aandoeningen |
| PRNPprion protein (Kanno blood group) | Heel vaak (80–99%) | In 4 aandoeningen |
| SLC6A19solute carrier family 6 member 19 | Heel vaak (80–99%) | In 2 aandoeningen |
| ANGangiogenin | Vaak (30–79%) | In 1 aandoening |
| ANXA11annexin A11 | Vaak (30–79%) | In 1 aandoening |
| ARMC5armadillo repeat containing 5 | Vaak (30–79%) | In 1 aandoening |
| ARSAarylsulfatase A | Vaak (30–79%) | In 4 aandoeningen |
| ATRXATRX chromatin remodeler | Vaak (30–79%) | In 1 aandoening |
| ATXN2ataxin 2 | Vaak (30–79%) | In 1 aandoening |
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Vaak (30–79%) | In 1 aandoening |
| CCNFcyclin F | Vaak (30–79%) | In 1 aandoening |
| CDH23cadherin related 23 | Vaak (30–79%) | In 1 aandoening |
| CFAP410cilia and flagella associated protein 410 | Vaak (30–79%) | In 1 aandoening |
| CHCHD10coiled-coil-helix-coiled-coil-helix domain containing 10 | Vaak (30–79%) | In 1 aandoening |
| CHMP2Bcharged multivesicular body protein 2B | Vaak (30–79%) | In 1 aandoening |
| CREBBPCREB binding lysine acetyltransferase | Vaak (30–79%) | In 2 aandoeningen |
| DAOD-amino acid oxidase | Vaak (30–79%) | In 1 aandoening |
| DCTN1dynactin subunit 1 | Vaak (30–79%) | In 1 aandoening |
| EP300EP300 lysine acetyltransferase | Vaak (30–79%) | In 1 aandoening |
| EPM2AEPM2A glucan phosphatase, laforin | Vaak (30–79%) | In 1 aandoening |
| ERBB4erb-b2 receptor tyrosine kinase 4 | Vaak (30–79%) | In 1 aandoening |
| FAM177A1family with sequence similarity 177 member A1 | Vaak (30–79%) | In 1 aandoening |
| FIG4FIG4 phosphoinositide 5-phosphatase | Vaak (30–79%) | In 1 aandoening |
| FMO3flavin containing dimethylaniline monoxygenase 3 | Vaak (30–79%) | In 1 aandoening |
| FTLferritin light chain | Vaak (30–79%) | In 2 aandoeningen |
| FUSFUS RNA binding protein | Vaak (30–79%) | In 1 aandoening |
| GLE1GLE1 RNA export mediator | Vaak (30–79%) | In 1 aandoening |
| GLT8D1glycosyltransferase 8 domain containing 1 | Vaak (30–79%) | In 1 aandoening |
| GNASGNAS complex locus | Vaak (30–79%) | In 2 aandoeningen |
| HNRNPA1heterogeneous nuclear ribonucleoprotein A1 | Vaak (30–79%) | In 1 aandoening |
Toon nog 128 genen
| Gen | Hoe vaak het voorkomt | Aandoeningen |
|---|---|---|
| KDM1Alysine demethylase 1A | Vaak (30–79%) | In 1 aandoening |
| LRP12LDL receptor related protein 12 | Vaak (30–79%) | In 1 aandoening |
| MATR3matrin 3 | Vaak (30–79%) | In 1 aandoening |
| MTPAPmitochondrial poly(A) polymerase | Vaak (30–79%) | In 2 aandoeningen |
| NEFHneurofilament heavy chain | Vaak (30–79%) | In 1 aandoening |
| NEK1NIMA related kinase 1 | Vaak (30–79%) | In 1 aandoening |
| NHLRC1NHL repeat containing E3 ubiquitin protein ligase 1 | Vaak (30–79%) | In 1 aandoening |
| NOTCH3notch receptor 3 | Vaak (30–79%) | In 1 aandoening |
| NR3C1nuclear receptor subfamily 3 group C member 1 | Vaak (30–79%) | In 1 aandoening |
| NTRK1neurotrophic receptor tyrosine kinase 1 | Vaak (30–79%) | In 1 aandoening |
| OPTNoptineurin | Vaak (30–79%) | In 1 aandoening |
| PANK2pantothenate kinase 2 | Vaak (30–79%) | In 1 aandoening |
| PFN1profilin 1 | Vaak (30–79%) | In 1 aandoening |
| PRPHperipherin | Vaak (30–79%) | In 1 aandoening |
| PSAPprosaposin | Vaak (30–79%) | In 3 aandoeningen |
| SLC39A4solute carrier family 39 member 4 | Vaak (30–79%) | In 2 aandoeningen |
| SLC6A17solute carrier family 6 member 17 | Vaak (30–79%) | In 2 aandoeningen |
| SNORD118small nucleolar RNA, C/D box 118 | Vaak (30–79%) | In 1 aandoening |
| SOD1superoxide dismutase 1 | Vaak (30–79%) | In 1 aandoening |
| SPG11SPG11 vesicle trafficking associated, spatacsin | Vaak (30–79%) | In 1 aandoening |
| SPTBN1spectrin beta, non-erythrocytic 1 | Vaak (30–79%) | In 1 aandoening |
| SQSTM1sequestosome 1 | Vaak (30–79%) | In 1 aandoening |
| SRPK3SRSF protein kinase 3 | Vaak (30–79%) | In 1 aandoening |
| TAF15TATA-box binding protein associated factor 15 | Vaak (30–79%) | In 1 aandoening |
| TARDBPTAR DNA binding protein | Vaak (30–79%) | In 2 aandoeningen |
| TBK1TANK binding kinase 1 | Vaak (30–79%) | In 1 aandoening |
| TP53tumor protein p53 | Vaak (30–79%) | In 1 aandoening |
| TREM2triggering receptor expressed on myeloid cells 2 | Vaak (30–79%) | In 1 aandoening |
| UBQLN2ubiquilin 2 | Vaak (30–79%) | In 1 aandoening |
| UNC13Aunc-13 homolog A | Vaak (30–79%) | In 1 aandoening |
| USP48ubiquitin specific peptidase 48 | Vaak (30–79%) | In 1 aandoening |
| USP8ubiquitin specific peptidase 8 | Vaak (30–79%) | In 2 aandoeningen |
| VAPBVAMP associated protein B and C | Vaak (30–79%) | In 1 aandoening |
| VCPvalosin containing protein | Vaak (30–79%) | In 2 aandoeningen |
| ARL6ARF like GTPase 6 | Soms (5–29%) | In 1 aandoening |
| ATP1A2ATPase Na+/K+ transporting subunit alpha 2 | Soms (5–29%) | In 1 aandoening |
| ATP1A3ATPase Na+/K+ transporting subunit alpha 3 | Soms (5–29%) | In 3 aandoeningen |
| BBIP1BBSome interacting protein 1 | Soms (5–29%) | In 1 aandoening |
| BBS1Bardet-Biedl syndrome 1 | Soms (5–29%) | In 1 aandoening |
| BBS10Bardet-Biedl syndrome 10 | Soms (5–29%) | In 1 aandoening |
| BBS12Bardet-Biedl syndrome 12 | Soms (5–29%) | In 1 aandoening |
| BBS2Bardet-Biedl syndrome 2 | Soms (5–29%) | In 1 aandoening |
| BBS4Bardet-Biedl syndrome 4 | Soms (5–29%) | In 1 aandoening |
| BBS5Bardet-Biedl syndrome 5 | Soms (5–29%) | In 1 aandoening |
| BBS7Bardet-Biedl syndrome 7 | Soms (5–29%) | In 1 aandoening |
| BBS9Bardet-Biedl syndrome 9 | Soms (5–29%) | In 1 aandoening |
| BPTFbromodomain PHD finger transcription factor | Soms (5–29%) | In 1 aandoening |
| BSNDbarttin CLCNK type accessory subunit beta | Soms (5–29%) | In 1 aandoening |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Soms (5–29%) | In 1 aandoening |
| CEP19centrosomal protein 19 | Soms (5–29%) | In 1 aandoening |
| CEP290centrosomal protein 290 | Soms (5–29%) | In 1 aandoening |
| CFAP418cilia and flagella associated protein 418 | Soms (5–29%) | In 1 aandoening |
| CLCNKAchloride voltage-gated channel Ka | Soms (5–29%) | In 1 aandoening |
| CLCNKBchloride voltage-gated channel Kb | Soms (5–29%) | In 1 aandoening |
| CTSFcathepsin F | Soms (5–29%) | In 1 aandoening |
| GABRG2gamma-aminobutyric acid type A receptor subunit gamma2 | Soms (5–29%) | In 1 aandoening |
| GALCgalactosylceramidase | Soms (5–29%) | In 1 aandoening |
| GRIK2glutamate ionotropic receptor kainate type subunit 2 | Soms (5–29%) | In 1 aandoening |
| GRIN2Aglutamate ionotropic receptor NMDA type subunit 2A | Soms (5–29%) | In 2 aandoeningen |
| HTRA1HtrA serine peptidase 1 | Soms (5–29%) | In 1 aandoening |
| IFT172intraflagellar transport 172 | Soms (5–29%) | In 1 aandoening |
| IFT27intraflagellar transport 27 | Soms (5–29%) | In 1 aandoening |
| IFT74intraflagellar transport 74 | Soms (5–29%) | In 1 aandoening |
| LZTFL1leucine zipper transcription factor like 1 | Soms (5–29%) | In 1 aandoening |
| MECP2methyl-CpG binding protein 2 | Soms (5–29%) | In 1 aandoening |
| MIR17HGmiR-17-92a-1 cluster host gene | Soms (5–29%) | In 1 aandoening |
| MKKSMKKS centrosomal shuttling protein | Soms (5–29%) | In 1 aandoening |
| MKS1MKS transition zone complex subunit 1 | Soms (5–29%) | In 1 aandoening |
| MT-TL2mitochondrially encoded tRNA-Leu (CUN) 2 | Soms (5–29%) | In 1 aandoening |
| NAGSN-acetylglutamate synthase | Soms (5–29%) | In 1 aandoening |
| NPHP1nephrocystin 1 | Soms (5–29%) | In 1 aandoening |
| PLA2G6phospholipase A2 group VI | Soms (5–29%) | In 2 aandoeningen |
| POLGDNA polymerase gamma, catalytic subunit | Soms (5–29%) | In 2 aandoeningen |
| PSMD12proteasome 26S subunit, non-ATPase 12 | Soms (5–29%) | In 1 aandoening |
| RFX7regulatory factor X7 | Soms (5–29%) | In 1 aandoening |
| RHOBTB2Rho related BTB domain containing 2 | Soms (5–29%) | In 1 aandoening |
| RNF125ring finger protein 125 | Soms (5–29%) | In 1 aandoening |
| RNF168ring finger protein 168 | Soms (5–29%) | In 1 aandoening |
| RNU2-2RNA, U2 small nuclear 2 | Soms (5–29%) | In 1 aandoening |
| SARDHsarcosine dehydrogenase | Soms (5–29%) | In 1 aandoening |
| SATB2SATB homeobox 2 | Soms (5–29%) | In 1 aandoening |
| SCAPERS-phase cyclin A associated protein in the ER | Soms (5–29%) | In 1 aandoening |
| SCLT1sodium channel and clathrin linker 1 | Soms (5–29%) | In 1 aandoening |
| SCN2Asodium voltage-gated channel alpha subunit 2 | Soms (5–29%) | In 1 aandoening |
| SDCCAG8SHH signaling and ciliogenesis regulator SDCCAG8 | Soms (5–29%) | In 1 aandoening |
| SLC1A3solute carrier family 1 member 3 | Soms (5–29%) | In 1 aandoening |
| SLC2A1solute carrier family 2 member 1 | Soms (5–29%) | In 1 aandoening |
| SPARTspartin | Soms (5–29%) | In 2 aandoeningen |
| SRPX2sushi repeat containing protein X-linked 2 | Soms (5–29%) | In 1 aandoening |
| TNIKTRAF2 and NCK interacting kinase | Soms (5–29%) | In 1 aandoening |
| TRIM32tripartite motif containing 32 | Soms (5–29%) | In 1 aandoening |
| TTC8tetratricopeptide repeat domain 8 | Soms (5–29%) | In 1 aandoening |
| TUBB3tubulin beta 3 class III | Soms (5–29%) | In 1 aandoening |
| TWNKtwinkle mtDNA helicase | Soms (5–29%) | In 1 aandoening |
| VPS13Avacuolar protein sorting 13 homolog A | Soms (5–29%) | In 2 aandoeningen |
| WDPCPWD repeat containing planar cell polarity effector | Soms (5–29%) | In 1 aandoening |
| AKT1AKT serine/threonine kinase 1 | Zelden (1–4%) | In 1 aandoening |
| BAP1BRCA1 associated deubiquitinase 1 | Zelden (1–4%) | In 1 aandoening |
| NF2NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor | Zelden (1–4%) | In 1 aandoening |
| PDGFBplatelet derived growth factor subunit B | Zelden (1–4%) | In 1 aandoening |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Zelden (1–4%) | In 1 aandoening |
| SMARCB1SWI/SNF related BAF chromatin remodeling complex subunit B1 | Zelden (1–4%) | In 1 aandoening |
| SMARCE1SWI/SNF related BAF chromatin remodeling complex subunit E1 | Zelden (1–4%) | In 1 aandoening |
| SMOsmoothened, frizzled class receptor | Zelden (1–4%) | In 1 aandoening |
| SUFUSUFU negative regulator of hedgehog signaling | Zelden (1–4%) | In 1 aandoening |
| TERTtelomerase reverse transcriptase | Zelden (1–4%) | In 1 aandoening |
| TRAF7TNF receptor associated factor 7 | Zelden (1–4%) | In 1 aandoening |
| AIPAHR interacting HSP90 co-chaperone | Niet vastgelegd | In 1 aandoening |
| B4GALNT1beta-1,4-N-acetyl-galactosaminyltransferase 1 | Niet vastgelegd | In 1 aandoening |
| BCS1LBCS1 ubiquinol-cytochrome c reductase complex chaperone | Niet vastgelegd | In 1 aandoening |
| C19orf12chromosome 19 open reading frame 12 | Niet vastgelegd | In 1 aandoening |
| CUL4Bcullin 4B | Niet vastgelegd | In 1 aandoening |
| DGCR2DiGeorge syndrome critical region gene 2 | Niet vastgelegd | In 1 aandoening |
| DGCR6DiGeorge syndrome critical region gene 6 | Niet vastgelegd | In 1 aandoening |
| DGCR8DGCR8 microprocessor complex subunit | Niet vastgelegd | In 1 aandoening |
| EIF2B1eukaryotic translation initiation factor 2B subunit alpha | Niet vastgelegd | In 1 aandoening |
| ELP1elongator acetyltransferase complex subunit 1 | Niet vastgelegd | In 1 aandoening |
| ESS2ess-2 spliceosome associated protein | Niet vastgelegd | In 1 aandoening |
| HLA-DQB1major histocompatibility complex, class II, DQ beta 1 | Niet vastgelegd | In 1 aandoening |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Niet vastgelegd | In 1 aandoening |
| MED12mediator complex subunit 12 | Niet vastgelegd | In 1 aandoening |
| PDE11Aphosphodiesterase 11A | Niet vastgelegd | In 1 aandoening |
| PGK1phosphoglycerate kinase 1 | Niet vastgelegd | In 1 aandoening |
| PRKACAprotein kinase cAMP-activated catalytic subunit alpha | Niet vastgelegd | In 1 aandoening |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Niet vastgelegd | In 1 aandoening |
| TBX1T-box transcription factor 1 | Niet vastgelegd | In 1 aandoening |
| TDO2tryptophan 2,3-dioxygenase | Niet vastgelegd | In 1 aandoening |
| ZFYVE26zinc finger FYVE-type containing 26 | Niet vastgelegd | In 1 aandoening |
Hoe vaak dit voorkomt bij mensen met een van de aandoeningen van het gen, de hoogste frequentie binnen die aandoeningen, zoals de Human Phenotype Ontology dit vastlegt. Deze pagina's beschrijven kenmerken en het onderzoek erachter; het zijn geen diagnose, en over symptomen kunt u het best een arts of genetisch adviseur raadplegen.
Bredere kenmerken
Waar dit vandaan komt
- De Human Phenotype Ontology, release 2026-09-01: het kenmerk, de namen, de definitie en de genen die ermee verbonden zijn. Meer informatie vindt u op hpo.jax.org.
- Gegevensrelease 2026.10.16-c6eea6bf.
Voor wie we er zijnOnze wetenschapProductenResultaten
InloggenVraagAan de slagvanaf $ 449
Eén test. Een leven lang antwoorden.
Vanaf $ 449Gratis verzending · Resultaten binnen 6–8 weken